Using Outcomes to Guide Treatment of Surgical Emergencies

利用结果指导外科紧急情况的治疗

基本信息

  • 批准号:
    10152509
  • 负责人:
  • 金额:
    $ 50.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-05-15 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

Emergency general surgery (EGS) conditions are defined by a group of acute, non-trauma diagnoses that require presentation to an emergency department for operative or non-operative care. In the US, 3-4 million adults are hospitalized and treated for an EGS condition each year such that EGS conditions are responsible for 7% of all hospitalizations. EGS conditions result in an estimated 800,000 operations annually and cost ≈ $28 billion. The burden of EGS on inpatient care is greater than that of a new diagnosis of diabetes or cancer, coronary heart disease, heart failure, stroke, or HIV. Older adults, who are at increased risk of adverse outcomes, comprise more than half of the adult EGS population. Operative management of EGS conditions results in an overall complication rate of 50%, with a readmission rate of 4-18%, and a mortality rate that can approach 15%, with older patients demonstrating a significantly higher risk. Non-operative management is considered a reasonable alternative yet studies show mixed results. Randomized control trials are limited by the invasive nature of operative treatment, the heterogeneity of conditions, and the acute nature of EGS. Furthermore, most trials have compared different types of operative or non-operative interventions, with relatively few comparing operative treatment to non-operative treatment. A lack of evidence on the comparative effectiveness of operative and non- operative treatment has been shown to result in unnecessary variations in treatment and inferior operative outcomes. Furthermore, given the growing interest in the development of a regionalized system of care for EGS patients since the Institute of Medicine Committee report on the Future of Emergency Care in the United States Health System, knowledge on hospital performance in EGS is needed. This proposal aims to address these gaps in the literature with the following specific aims: (1) To identify hospital-level factors associated with rankings in EGS performance, (2) To evaluate the comparative effectiveness of operative and non-operative treatment in specific EGS conditions and (3) To evaluate heterogeneity in the effectiveness of operative treatment. Conditional effects of age, dementia and race will be examined amongst others. Using nationwide data from Medicare beneficiaries, the proposed study will be the first comparative effectiveness analysis of operative and non-operative treatment in EGS. The proposal employs: (1) template matching to define hospital quality in EGS (2) an instrumental variable approach with optimal near-far matching to overcome confounding by indication and, (3) interaction models to examine the conditional relationship between treatment and outcomes by patient factors. In so doing, the findings will provide insights into hospital factors necessary for optimal EGS outcomes and the comparative effectiveness of OP of EGS conditions. Policy makers will have evidence to inform systems- level restructuring to address the crisis in emergency care. Patients, caregivers and providers will benefit from the resultant high value care.
急诊普通外科(EGS)条件是由一组急性,非创伤诊断,需要 在急诊科进行手术或非手术护理。在美国,300万至400万成年人 每年因EGS状况住院和治疗,使得EGS状况占所有患者的7%。 住院治疗环境商品和服务条件每年造成估计80万次手术,耗资280亿美元。的 EGS对住院治疗的负担大于新诊断的糖尿病或癌症、冠心病 心脏衰竭中风或艾滋病老年人,谁是在不良后果的风险增加,包括 超过一半的成年EGS人口。EGS条件的手术管理导致总体 并发症发生率为50%,再入院率为4- 18%,死亡率可接近15%, 老年患者的风险明显更高。非手术治疗被认为是合理的 然而,其他研究显示出好坏参半的结果。随机对照试验受到创伤性的限制, 手术治疗、病情的异质性和EGS的急性性质。此外,大多数审判 比较了不同类型的手术或非手术干预,比较手术干预的相对较少。 非手术治疗。缺乏关于手术和非手术的相对有效性的证据, 手术治疗已被证明会导致治疗中不必要的变化, 结果。此外,鉴于人们对发展区域化的环境和营养服务系统的兴趣日益浓厚, 自医学研究所委员会关于美国急诊护理未来的报告以来, 卫生系统,需要了解EGS中的医院绩效。该提案旨在解决这些问题 在文献中的差距与以下具体目标:(1)确定医院水平的因素与排名 (2)比较手术与非手术治疗对EGS的疗效, (3)评价手术治疗效果的异质性。 年龄、痴呆和种族的条件效应将被检查。使用来自全国的数据 医疗保险受益人,拟议的研究将是第一个比较有效的分析, EGS的非手术治疗。该方案采用:(1)模板匹配法定义EGS中的医院质量 (2)具有最佳远近匹配的工具变量方法,以克服指示的混淆, (3)相互作用模型,以检查治疗与患者结局之间的条件关系 因素在这样做的过程中,研究结果将提供对最佳EGS结果所需的医院因素的见解 以及EGS条件下OP的相对有效性。政策制定者将有证据告知系统- 一级重组,以解决危机的紧急护理。患者、护理人员和提供者将受益于 由此产生的高价值护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rachel Kelz其他文献

Rachel Kelz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rachel Kelz', 18)}}的其他基金

Personalized Provider Selection to Reduce Surgical Disparities
个性化的医疗服务提供者选择以减少手术差异
  • 批准号:
    10624968
  • 财政年份:
    2022
  • 资助金额:
    $ 50.29万
  • 项目类别:
Personalized Provider Selection to Reduce Surgical Disparities
个性化的医疗服务提供者选择以减少手术差异
  • 批准号:
    10445916
  • 财政年份:
    2022
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
  • 批准号:
    10402798
  • 财政年份:
    2019
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
  • 批准号:
    10667738
  • 财政年份:
    2019
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
  • 批准号:
    10370161
  • 财政年份:
    2019
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
  • 批准号:
    10828099
  • 财政年份:
    2019
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Outcomes to Guide Treatment of Surgical Emergencies
利用结果指导外科紧急情况的治疗
  • 批准号:
    10619027
  • 财政年份:
    2019
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
  • 批准号:
    9118829
  • 财政年份:
    2015
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
  • 批准号:
    9308803
  • 财政年份:
    2015
  • 资助金额:
    $ 50.29万
  • 项目类别:
Using Patient Outcomes to Inform Surgical Education
利用患者结果为外科教育提供信息
  • 批准号:
    8985515
  • 财政年份:
    2015
  • 资助金额:
    $ 50.29万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 50.29万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了